Acetazolamide drug interactions: Difference between revisions

Jump to navigation Jump to search
ShiSheng (talk | contribs)
Created page with "__NOTOC__ {{Acetazolamide}} {{CMG}}; {{AE}} {{SS}} ==Drug Interactions== ===Aspirin - See WARNINGS=== DIAMOX modifies phenytoin metabolism with increased serum levels of ph..."
 
ShiSheng (talk | contribs)
 
(One intermediate revision by the same user not shown)
Line 1: Line 1:
__NOTOC__
#REDIRECT [[Acetazolamide#Drug Interactions]]
{{Acetazolamide}}
{{CMG}}; {{AE}} {{SS}}
 
==Drug Interactions==
 
===Aspirin - See WARNINGS===
 
DIAMOX modifies phenytoin metabolism with increased serum levels of phenytoin. This may increase or enhance the occurrence of osteomalacia in some patients receiving chronic phenytoin therapy. Caution is advised in patients receiving chronic concomitant therapy. By decreasing the gastrointestinal absorption of primidone, DIAMOX may decrease serum concentrations of primidone and its metabolites, with a consequent possible decrease in anticonvulsant effect. Caution is advised when beginning, discontinuing, or changing the dose of DIAMOX in patients receiving primidone.
 
Because of possible additive effects with other carbonic anhydrase inhibitors, concomitant use is not advisable.
 
Acetazolamide may increase the effects of other folic acid antagonists.
 
Acetazolamide decreases urinary excretion of amphetamine and may enhance the magnitude and duration of their effect.
 
Acetazolamide reduces urinary excretion of quinidine and may enhance its effect.
 
Acetazolamide may prevent the urinary antiseptic effect of methenamine. Acetazolamide increases lithium excretion and the lithium may be decreased.
 
Acetazolamide and sodium bicarbonate used concurrently increase the risk of renal calculus formation.
 
Acetazolamide may elevate cyclosporine levels.
 
===Drug/laboratory test interactions===
 
Sulfonamides may give false negative or decreased values for urinary phenolsulfonphthalein and phenol red elimination values for urinary protein, serum non-protein, and serum uric acid. Acetazolamide may produce an increased level of crystals in the urine.
 
Acetazolamide interferes with the HPLC method of assay for theophylline. Interference with the theophylline assay by acetazolamide depends on the solvent used in the extraction; acetazolamide may not interfere with other assay methods for theophylline.<ref name="dailymed.nlm.nih.gov">{{Cite web  | last =  | first =  | title = DIAMOX SEQUELS (ACETAZOLAMIDE) CAPSULE, EXTENDED RELEASE [DURAMED PHARMACEUTICALS, INC.] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=74e47451-2bc8-496e-88ad-c10002ee8e22 | publisher =  | date =  | accessdate = 25 February 2014 }}</ref>
 
==References==
{{reflist|2}}
 
{{Anticonvulsants}}
{{Antiglaucoma preparations and miotics}}
{{Diuretics}}
 
[[Category:Carbonic anhydrase inhibitors]]
[[Category:Mountaineering and health]]
[[Category:Anticonvulsants]]
[[Category:Sulfonamides]]
[[Category:World Health Organization essential medicines]]
[[Category:Thiadiazoles]]
[[Category:Amides]]
[[Category:Cardiovascular Drugs]]
[[Category:Drugs]]

Latest revision as of 15:10, 21 July 2014